Previous studies indicated that promoter methylation of O-6-methylguanine-DNA methyltransferase (MGMT), a key member involved in the DNA repair, would increase the sensitivity of glioma cells or tissues to TMZ (Oldrini et al., 2020). This evidence concerns the gene MGMT and central nervous system cancer.